NEUROTHERA LABS INC (NTLX.CA) Stock Income Statement
Canada - TSX Venture Exchange - TSX-V:NTLX - CA60700R1073 - Common Stock
0.165 CAD
0 (0%)
| TTM (2025-7-31) | 2025 (2025-1-31) | 2024 (2024-1-31) | 2023 (2023-1-31) | 2022 (2022-1-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 212.60K | 255.50K | 104.70K | 79.90K | 152.80K | |||
| Selling, General, and Administrative Expenses | 212.60K | 255.50K | 104.70K | 79.90K | 149.90K | |||
| Operating Income | -212.60K | -255.50K | -104.70K | -79.90K | -152.80K | |||
| Income Before Taxes | -212.60K | -255.50K | -104.70K | -79.90K | -152.80K | |||
| Net Income | -212.60K | -255.50K | -104.70K | -79.90K | -152.80K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.00 | -0.03 | |||
| Statistics | ||||||||
All data in CAD